Epidemiology of rosacea in Colombia

dc.contributor.authorRueda Jaime, Lili Johana
dc.contributor.authorMotta Beltrán, Adriana
dc.contributor.authorPabón, Juan G.
dc.contributor.authorBarona, Maria I.
dc.contributor.authorMeléndez, Esperanza
dc.contributor.authorOrozco, Beatriz
dc.contributor.authorRojas, Ricardo F.
dc.contributor.orcidMotta, Adriana [0000-0002-1924-1256]
dc.contributor.orcidMotta Beltrán, Adriana [0000-0002-1924-1256]
dc.contributor.orcidRueda Jaime, Lili Johana [0000-0003-3261-5299]
dc.contributor.orcidMotta Beltrán, Adriana [0000-0002-1924-1256]
dc.contributor.orcidRueda Jaime, Lili Johana [0000-0003-3261-5299]
dc.date.accessioned2020-11-20T20:09:13Z
dc.date.available2020-11-20T20:09:13Z
dc.date.issued2020
dc.description.abstractenglishPrevalence of rosacea has been estimated around the world in the range of 0–22%. In Colombia, the prevalence of rosacea remains unknown. The aim of this study was to determine the prevalence of rosacea and the frequencies of its subtypes in Colombia. This cross‐sectional, multicenter study was conducted in six outpatient dermatology clinics across Colombia. A total of 33 dermatologists conducted a comprehensive medical history and physical examination for all rosacea patients seen at their offices over the course of 2 months. All patients who accepted to participate were encouraged to answer a survey about the history of their illness. Of 10,204 outpatients evaluated for rosacea between July and August 2014, 291 rosacea patients were included in this study. The prevalence of rosacea subtypes in this cohort was: 45.3% erythematotelangiectatic (ETR) (n = 132), 48.7% papulopustular (PPR) (n = 142), 4.8% phymatous (n = 14), and 1% ocular (n = 3). Overall, the prevalence in Colombia was 2.85%. Our data represent an important first step to understanding the current state of rosacea in Colombia. The prevalence of rosacea in Colombia is the highest in Latin America among a few reports published, which might be explained by geographic features. However, contrary to our expectations, the prevalence is lower than that in some European countries. We postulate that this finding may be due to methodological differences.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1111/ijd.13491
dc.identifier.instnameinstname:Universidad El Bosquespa
dc.identifier.issn1365-4632
dc.identifier.reponamereponame:Repositorio Institucional Universidad El Bosquespa
dc.identifier.repourlrepourl:https://repositorio.unbosque.edu.co
dc.identifier.urihttps://hdl.handle.net/20.500.12495/5106
dc.language.isoeng
dc.publisherSpringer Linkspa
dc.publisher.journalInternational Journal of Dermatologyspa
dc.relation.ispartofseriesInternational Journal of Dermatology, 1365-4632, Vol. 56, No. 5, 2017, p. 510-513spa
dc.relation.urihttps://onlinelibrary.wiley.com/doi/abs/10.1111/ijd.13491
dc.rights.accessrightshttps://purl.org/coar/access_right/c_abf2
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.accessrightsAcceso abierto
dc.rights.creativecommons2017
dc.rights.localAcceso abiertospa
dc.subject.armarcEpidemiologíaspa
dc.subject.armarcRosáceaspa
dc.subject.armarcEstudios de evaluación como asuntospa
dc.titleEpidemiology of rosacea in Colombiaspa
dc.title.translatedEpidemiology of rosacea in Colombiaspa
dc.type.coarhttps://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
dc.type.hasversioninfo:eu-repo/semantics/publishedVersion
dc.type.localArtículo de revista

Archivos

Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:

Colecciones